News
PARIS, France and TARRYTOWN, NY, USA I May 30, 2025 I The AERIFY-1 phase 3 study evaluating itepekimab in former smokers with inadequately controlled chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback